Search Results - "Mattle, Anna G"

Medical Cannabis in the Treatment of Parkinson’s Disease by Aladeen, Traci S., Mattle, Anna G., Zelen, Kory, Mesha, Moustafa, Rainka, Michelle M., Geist, Tanya, Myers, Bennett, Mechtler, Laszlo

“…Medical cannabis (MC) has recently garnered interest as a potential treatment for neurologic diseases, including Parkinson's disease (PD). A retrospective…”
Get full text

Half-Life Extension and Biodistribution Modulation of Biotherapeutics via Red Blood Cell Hitch-Hiking with Novel Anti-Band 3 Single-Domain Antibodies by Nguyen, Toan D, Bordeau, Brandon M, Zhang, Yu, Mattle, Anna G, Balthasar, Joseph P

“…Small therapeutic proteins are receiving increased interest as therapeutic drugs; however, their clinical success has been limited due to their rapid…”
Get full text

Gabapentin to treat acute alcohol withdrawal in hospitalized patients: A systematic review and meta-analysis by Mattle, Anna G., McGrath, Patrick, Sanu, Austin, Kunadharaju, Rajesh, Kersten, Brian, Zammit, Kimberly, Mammen, Manoj J.

“…Gabapentin is an antiepileptic medication with evidence of benefit in alcohol use disorder patients. The mechanism of action of gabapentin may also benefit…”
Get full text

Medical Cannabis in the Treatment of Parkinson’s Disease by Aladeen, Traci S., Mattle, Anna G., Zelen, Kory, Mesha, Moustafa, Rainka, Michelle M., Geist, Tanya, Myers, Bennett, Mechtler, Laszlo

“…Medical cannabis (MC) has recently garnered interest as a potential treatment for neurologic diseases, including Parkinson's disease (PD). A retrospective…”
Get full text

Multiple Sclerosis and Use of Medical Cannabis: A Retrospective Review of a Neurology Outpatient Population by Rainka, Michelle M, Aladeen, Traci S, Mattle, Anna G, Lewandowski, Emily, Vanini, Denis, McCormack, Katelyn, Mechtler, Laszlo

“…Patients diagnosed as having multiple sclerosis (MS) experience a wide range of symptoms requiring pharmacologic management, and many do not achieve adequate…”
Get full text

Impact of medication optimization and recommendations by clinical pharmacists embedded in a memory disorder clinic by Coli, Katherine G., Lee, Monica, Aladeen, Traci S., Mattle, Anna G., Ajtai, Bela, Rainka, Michelle M.

“…Introduction Older patients with dementia or mild cognitive impairment (MCI) are particularly vulnerable to adverse effects from potentially inappropriate…”
Get full text

Evaluating outcomes of a clinical pharmacist medication management program in a multidisciplinary practice for outpatient buprenorphine treatment of opioid use disorder by Mattle, Anna G., Aladeen, Traci, Blondell, Richard D., Capote, Horacio, Rainka, Michelle

“…Introduction Treatment with medications such as buprenorphine has been shown to improve outcomes of patients with opioid use disorder (OUD); however, there is…”
Get full text